Psychedeic-Chronicle-Logo

Suggestions

  • Psychedelic News
  • DMT
  • Ketamine
  • Mescaline
  • Psilocybin
  • CEO INTERVIEWS

Psychedeic-Chronicle-Logo

Psychedelic News - Page 3

Choose Ketamine Complete Seed Capital Raise to Expand Technology Platform Psychedeic-Chronicle-Logo-White
Psychedelic News

Choose Ketamine Complete Capital Raise to Expand Technology Platform

February 16, 2023

In a major milestone for mental health care, Austin-based Choose Your Horizon Inc., also known as Choose Ketamine, has announced the completion of its seed financing round. Led by Manifestations Capital in collaboration with Notley Ventures and numerous industry veterans and thought leaders, this

Read More
Biomind Labs Secure Pre-IND Meeting, Seek FDA Feedback on New Triptax Depression Treatment Psychedeic-Chronicle-Logo-White
Psychedelic News

Biomind Labs Secure FDA Pre-IND Meeting for Feedback on NCE Triptax

October 14, 2022

The well-known psychedelic biotech company Biomind Labs Inc. (NEO: BMND) (OTC: BMNDF) (FSE: 3XI) announced that it has been granted a Pre-Investigational New Drug (Pre-IND) meeting by the U.S. Food and Drug Administration (FDA) for new chemical entity Triptax™. Biomind Labs is devoted to crafting innovative pharmaceuticals for patients with neurological and psychiatric disorders, using

Silo Pharma Initiate Toxicity Study of Ketamine Formulation for Fibromyalgia Treatment Psychedeic-Chronicle-Logo-White
October 10, 2022

Silo Pharma Initiate Toxicity Study of Ketamine Formulation for Fibromyalgia Treatment

Silo Pharma (Nasdaq: SILO), a developmental-stage psychedelic biopharmaceutical firm, announced today that

Numinus Develop Psilocybin Mushroom Tea Bags for Psychedelic Research Use Psychedeic-Chronicle-Logo-White
October 7, 2022

Numinus Develop Psilocybin Mushroom Tea Bags for Psychedelic Research Use

Numinus Wellness Inc.’s (OTCQX: NUMIF) (TSX: NUMI) research division, Numinus Bioscience, recently

MAPS-Launches-Online-Education-Curriculum-Psychedelic-Fundamentals Psychedeic-Chronicle-Logo-White
Psychedelic News

MAPS Launches New Online Education Curriculum ‘Psychedelic Fundamentals’

The first part in the new MAPS Digital Learning initiative is Psychedelic Fundamentals, which introduces those interested in learning to the fundamental

July 15, 2022
Zylorion Announces New U.S. Patent Filing For Novel Second-Generation Psilocybin-Based Compound Psychedeic-Chronicle-Logo-White
Psychedelic News

Zylorion Announces New U.S. Patent Filing For Novel Second-Generation Psilocybin-Based Compound

Zylorion announced today the filing of the Company’s third provisional patent application with the United States Patent and Trademark Office (“USPTO”). The

July 14, 2022
Ketamine Wellness Centers KWC Launches New Directory of Ketamine Therapists Psychedeic-Chronicle-Logo-White
Psychedelic News

Ketamine Wellness Centers (KWC) Launches New Directory of Ketamine Therapists

The nation’s largest ketamine therapy provider now offers complimentary patient resources supporting holistic mental health treatment. On Thursday, the largest ketamine therapy

July 1, 2022
Tryp Therapeutics Announces Psilyocbin-Assisted Patent Application for Binge Eating Disorder Treatment Psychedeic-Chronicle-Logo-White
Psychedelic News

Tryp Therapeutics Announces Psilyocbin-Assisted Patent Application for Binge Eating Disorder Treatment

Clinical-stage biotechnology Tryp Therapeutics, Inc. (CSE: TRYP) (OTCQB: TRYPF) has strengthened their intellectual property portfolio with a new provisional patent designed to treat

June 30, 2022
Previous 1 2 3

Recent Posts

  • Choose Ketamine Complete Capital Raise to Expand Technology Platform
  • Biomind Labs Secure FDA Pre-IND Meeting for Feedback on NCE Triptax
  • Silo Pharma Initiate Toxicity Study of Ketamine Formulation for Fibromyalgia Treatment
  • Numinus Develop Psilocybin Mushroom Tea Bags for Psychedelic Research Use
  • atai Life Sciences Announce First Subject Dosed in Synthetic DMT Phase 1 Trial

Recent Comments

No comments to show.

Popular

Choose Ketamine Complete Seed Capital Raise to Expand Technology Platform

Choose Ketamine Complete Capital Raise to Expand Technology Platform

In a major milestone for mental health care, Austin-based Choose

Biomind Labs Secure Pre-IND Meeting, Seek FDA Feedback on New Triptax Depression Treatment

Biomind Labs Secure FDA Pre-IND Meeting for Feedback on NCE Triptax

The well-known psychedelic biotech company Biomind Labs Inc. (NEO: BMND)

Silo Pharma Initiate Toxicity Study of Ketamine Formulation for Fibromyalgia Treatment

Silo Pharma Initiate Toxicity Study of Ketamine Formulation for Fibromyalgia Treatment

Silo Pharma (Nasdaq: SILO), a developmental-stage psychedelic biopharmaceutical firm, announced

Psychedeic-Chronicle-Logo

© 2022 PSYCHEDELIC CHRONICLE
ALL RIGHTS RESERVED.

  • Psychedelic News
  • DMT
  • Ketamine
  • Mescaline
  • Psilocybin
  • CEO INTERVIEWS